Latest Insights on OIS
Should You Invest In “Miracle Drug” Ozempic? November 17, 2023 Banyan Edge, Diversified Investments, Trending
From Chealsea Handler to Elon Musk, Novo Nordisk's Ozempic has been hailed a "miracle drug." Is it worth investing in?
Watch a CEO During Earnings Season for When to Invest November 15, 2023 Banyan Edge, Investing, Stocks
Every 13 weeks, all publicly traded companies file a quarterly report. It's "earnings season." Watch a company's CEO to take investing cues.
New Trading System Zeroes in on the Top 1% of Nasdaq Stocks November 10, 2023 Banyan Edge, Stocks, Trading Strategies
Nothing will transform your portfolio’s returns quite like a reliable trading system. This one zeroes in on the top 1% in the Nasdaq.
4 Reasons to Be Bullish on Charles Schwab Corporation (SCHW) November 8, 2023 Banyan Edge, Investment Opportunities, Stocks
The Charles Schwab Corporation (NYSE: SCHW) has been heralded the "worst-performing stock" in the S&P 500. Here's why you should be bullish.
Value Investing Isn’t the Only Way to Trade October 20, 2023 Banyan Edge, Investing, Stocks, Trading Strategies
Value is an important factor for a worthy stock, but here's why value investing alone is not a strategy. Try this stock rating tool!MEET OUR EXPERTS
Director of Investment Research
Editor of Alpha Investor
CEO of Banyan Hill
Editor of Precision Profits and Apex Alert
Chief Investment Strategist of Money & Markets
Editor of Strategic Fortunes and three elite services
Director of VIP Services
Research Analyst
